Neelam Goyal, MD | UniHealth

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Goyal’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A106343 · Current

Licensed to practise in California · since 2008 · expires 2028-11-30 · State University of New York Health Science Center at Brooklyn.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$31,356

Medicare paid this office $31,356 for 160 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	73	$12,523	$117
Nerve test	19	$3,213	$169
Nerve test	27	$3,209	$119
Muscle electrical test	49	$2,633	$41
New patient visit (60+ min)	13	$1,954	$150

See all 9 services

Sort by

Every Original Medicare service billed

Long return visit (40+ min)	73	$12,523	$117
Nerve test	19	$3,213	$169
Nerve test	27	$3,209	$119
Muscle electrical test	49	$2,633	$41
New patient visit (60+ min)	13	$1,954	$150
Testing of nerve-muscle junction	15	$1,162	$29
Muscle electrical test	34	$710	$17
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	14	$613	$27
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	15	$300	$15

Who their Medicare patients are

160 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 10% · Women 56% · Also on Medicaid 21% · Health risk score 1.74. Above the middle of the specialty; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 75% · Diabetes 36% · Coronary heart disease 34% · Chronic kidney disease 30% · Depression 28% · Cancer 21% · Heart failure 18% · Atrial fibrillation 18% · COPD 14% · Stroke 11% · Dementia 8%.

The office billed $767,962, Medicare allowed $42,004 and paid $31,356; for 403 services of 18 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	160	403	73	1.74	$767,962	$31,356
2023	246	627	72	1.65	$1,065,853	$54,246
2022	256	710	72	1.49	$838,392	$61,312
2021	230	625	71	1.78	$681,111	$57,229
2020	237	596	71	1.64	$720,192	$49,077
2019	257	660	73	1.43	$897,632	$57,418
2018	267	678	71	1.66	$945,491	$54,780
2017	344	916	70	1.51	$1,449,093	$74,558
2016	323	964	71	1.41	$1,601,782	$71,987
2015	289	793	71	1.46	$912,511	$66,245
2014	191	556	71	1.41	$409,314	$37,951
2013	279	762	70	1.46	$353,305	$57,709

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 9 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	118	$22,438	$119
New patient visit (60+ min)	38	$5,794	$152
Nerve test	43	$5,005	$116
Nerve test	30	$4,187	$140
Muscle electrical test	66	$3,289	$41
Nerve test	17	$2,921	$172
Initial hospital care with moderate level of medical decision making at least 75 minutes	16	$2,559	$160
Muscle electrical test	61	$1,673	$17
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	30	$991	$25

2022: 8 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	149	$29,688	$119
New patient visit (60+ min)	62	$10,171	$164
Nerve test	42	$4,781	$114
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	70	$3,054	$28
Muscle electrical test	54	$2,736	$41
Nerve test	18	$2,380	$132
Return visit (30+ min)	18	$1,536	$85
Muscle electrical test	48	$1,210	$17

2021: 9 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	113	$23,505	$124
New patient visit (60+ min)	68	$10,973	$161
Nerve test	31	$3,836	$124
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	58	$2,398	$30
Nerve test	16	$2,361	$148
Muscle electrical test	46	$2,192	$41
Return visit (30+ min)	21	$1,747	$76
Muscle electrical test	39	$1,024	$18
Testing of nerve-muscle junction	12	$992	$33

2020: 10 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	96	$13,951	$98
New patient visit (60+ min)	46	$6,354	$138
Return visit (30+ min)	64	$5,177	$70
Nerve test	33	$3,944	$120
Muscle electrical test	57	$2,823	$43
Extended office or other outpatient service, first hour	24	$2,823	$113
Nerve test	16	$2,454	$153
Long return visit (40+ min)	12	$1,360	$91
Nerve test	12	$1,251	$104
Muscle electrical test	47	$1,100	$15

2019: 10 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	111	$16,482	$92
New patient visit (60+ min)	76	$10,762	$142
Nerve test	31	$5,496	$177
Nerve test	31	$4,551	$147
Extended office or other outpatient service, first hour	36	$4,394	$110
Muscle electrical test	70	$3,737	$42
Nerve test	29	$3,638	$125
Muscle electrical test	60	$1,557	$17
Return visit (30+ min)	18	$1,435	$68
Muscle electrical test	14	$476	$34

2018: 15 services

Sort by

Original Medicare services billed in 2018

Long return visit (40+ min)	93	$12,430	$85
Long return visit (40+ min)	55	$5,686	$96
New patient visit (60+ min)	34	$4,708	$138
New patient visit (60+ min)	27	$4,064	$151
Nerve test	31	$3,694	$119
Nerve test	18	$3,129	$174
Nerve test	21	$2,932	$140
Extended office or other outpatient service, first hour	21	$2,486	$108
Muscle electrical test	47	$2,410	$39
Extended office or other outpatient service, first hour	12	$1,426	$110
Muscle electrical test	56	$1,410	$16
Nerve test	11	$1,364	$124
Muscle electrical test	22	$1,155	$43
Return visit (30+ min)	14	$832	$59
Muscle electrical test	23	$575	$16

2017: 10 services

Sort by

Original Medicare services billed in 2017

Long return visit (40+ min)	135	$19,487	$87
New patient visit (60+ min)	99	$14,144	$143
Nerve test	55	$7,828	$142
Nerve test	44	$7,429	$169
Nerve test	57	$6,847	$120
Muscle electrical test	117	$6,280	$39
Extended office or other outpatient service, first hour	50	$5,753	$107
Muscle electrical test	107	$2,538	$16
Return visit (30+ min)	23	$1,693	$68
Muscle electrical test	18	$624	$35

2016: 11 services

Sort by

Original Medicare services billed in 2016

Long return visit (40+ min)	106	$17,952	$95
New patient visit (60+ min)	80	$11,949	$149
Nerve test	73	$8,485	$116
Muscle electrical test	145	$8,063	$42
Nerve test	56	$7,817	$140
Nerve test	26	$4,464	$172
Muscle electrical test	127	$3,600	$17
Nerve test	34	$3,152	$93
Extended office or other outpatient service, first hour	31	$2,853	$84
Return visit (30+ min)	29	$2,059	$69
Muscle electrical test	12	$416	$35

2015: 11 services

Sort by

Original Medicare services billed in 2015

Long return visit (40+ min)	123	$19,242	$95
New patient visit (60+ min)	135	$18,953	$140
Nerve test	44	$5,357	$122
Extended office or other outpatient service, first hour	48	$4,533	$82
Muscle electrical test	84	$4,470	$42
Nerve test	23	$3,338	$145
Nerve test	24	$2,250	$94
Nerve test	13	$2,229	$171
Muscle electrical test	73	$2,089	$17
Return visit (30+ min)	16	$1,051	$62
Muscle electrical test	25	$873	$35

2014: 10 services

Sort by

Original Medicare services billed in 2014

Long return visit (40+ min)	93	$12,614	$84
New patient visit (60+ min)	47	$6,524	$139
Nerve test	40	$4,144	$104
Muscle electrical test	66	$3,326	$42
Extended office or other outpatient service, first hour	25	$2,417	$81
Nerve test	23	$2,071	$90
Muscle electrical test	67	$1,951	$17
Nerve test	13	$1,772	$136
Return visit (30+ min)	15	$1,119	$66
Muscle electrical test	13	$485	$35

2013: 10 services

Sort by

Original Medicare services billed in 2013

New patient visit (60+ min)	121	$16,680	$138
Long return visit (40+ min)	117	$15,761	$89
Nerve test	36	$4,097	$114
Extended office or other outpatient service, first hour	48	$3,967	$79
Muscle electrical test	68	$2,797	$33
Muscle electrical test	82	$2,564	$17
Nerve test	18	$2,524	$140
Nerve test	21	$1,818	$87
Return visit (30+ min)	21	$1,200	$55
Nerve test	12	$846	$71

Drugs they prescribed that Part D paid

$2,298,622

Pharmacies billed $2,298,622 in 2024. Most of that is one immune-globulin drugs at about $14,000 a fill for a small number of people.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 531) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.

433 generic and 98 brand-name prescriptions · $2,298,622 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Gamunex-C	Immune globulin	48	$684,518	$14,261
Mycophenolate Mofetil	None	113	$30,091	$266
Pyridostigmine	None	54	$3,899	$72
Azathioprine	None	16	$3,053	$191
Prednisone	None	124	$777	$6

See all 8 drugs

Sort by

Every Part D drug this clinician prescribed

Gamunex-C	Immune globulin	48	$684,518	$14,261
Mycophenolate Mofetil	None	113	$30,091	$266
Pyridostigmine	None	54	$3,899	$72
Azathioprine	None	16	$3,053	$191
Prednisone	None	124	$777	$6
Gabapentin	None	28	$725	$26
Methotrexate	None	27	$518	$19
Duloxetine	None	20	$137	$7

Year by year

Sort by

Part D prescribing by year

2024	531	79	0% (0)	18%	$2,298,622
2023	654	101	None	19%	$1,836,164
2022	749	103	0% (0)	25%	$2,416,560
2021	586	81	0% (0)	None	$696,523
2020	488	65	0% (0)	9%	$372,515
2019	533	71	None	21%	$915,256
2018	607	84	0% (0)	21%	$846,789
2017	495	80	None	7%	$194,845
2016	449	66	0% (0)	None	$59,581
2015	376	70	None	None	$334,599
2014	198	45	None	None	$277,635
2013	162	42	0% (0)	None	$27,752

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 10 drugs

Sort by

Part D drugs prescribed in 2023

Gamunex-C	Immune globulin	64	$775,438	$12,116
Radicava Ors	None	17	$231,187	$13,599
Mycophenolate Mofetil	None	105	$16,362	$156
Pyridostigmine	None	62	$4,814	$78
Gabapentin	None	94	$3,259	$35
Azathioprine	None	24	$3,170	$132
Pregabalin	None	26	$1,883	$72
Methotrexate	None	35	$1,757	$50
Duloxetine	None	22	$1,307	$59
Prednisone	None	113	$759	$7

2022: 17 drugs

Sort by

Part D drugs prescribed in 2022

Gamunex-C	Immune globulin	66	$787,034	$11,925
Gammaplex	Immune globulin	31	$260,953	$8,418
Radicava Ors	None	16	$223,695	$13,981
Gammagard Liquid	Immune globulin	19	$117,660	$6,193
Nuedexta	None	15	$35,072	$2,338
Mycophenolate Mofetil	None	100	$21,749	$217
Riluzole	None	18	$5,935	$330
Gabapentin	None	80	$4,498	$56
Pyridostigmine	None	69	$4,383	$64
Azathioprine	None	21	$2,769	$132
Prednisone	None	121	$1,217	$10
Methotrexate	None	25	$1,207	$48
Glycopyrrolate	None	20	$497	$25
Tizanidine	None	13	$435	$33
Amitriptyline	None	16	$311	$19
Pregabalin	None	23	$249	$11
Folic Acid	None	19	$73	$4

2021: 13 drugs

Sort by

Part D drugs prescribed in 2021

Gamunex-C	Immune globulin	40	$454,299	$11,357
Mycophenolate Mofetil	None	83	$13,455	$162
Pyridostigmine Bromide Er	None	16	$8,761	$548
Pyridostigmine	None	68	$4,651	$68
Riluzole	None	25	$2,617	$105
Gabapentin	None	63	$2,372	$38
Azathioprine	None	18	$1,744	$97
Prednisone	None	117	$904	$8
Methotrexate	None	25	$685	$27
Pregabalin	None	13	$667	$51
Duloxetine	None	17	$435	$26
Glycopyrrolate	None	16	$275	$17
Amitriptyline	None	17	$207	$12

2020: 10 drugs

Sort by

Part D drugs prescribed in 2020

Gamunex-C	Immune globulin	25	$240,600	$9,624
Mycophenolate Mofetil	None	76	$14,894	$196
Pyridostigmine Bromide Er	None	13	$9,837	$757
Pyridostigmine	None	43	$3,739	$87
Gabapentin	None	78	$1,853	$24
Methotrexate	None	38	$1,717	$45
Riluzole	None	16	$1,327	$83
Azathioprine	None	15	$989	$66
Prednisone	None	117	$854	$7
Glycopyrrolate	None	13	$341	$26

2019: 10 drugs

Sort by

Part D drugs prescribed in 2019

Radicava	None	33	$368,054	$11,153
Gamunex-C	Immune globulin	29	$291,874	$10,065
Nuedexta	None	24	$30,732	$1,281
Mycophenolate Mofetil	None	71	$11,712	$165
Pyridostigmine Bromide Er	None	11	$10,963	$997
Riluzole	None	35	$7,425	$212
Pyridostigmine	None	41	$4,446	$108
Gabapentin	None	66	$2,447	$37
Methotrexate	None	41	$1,011	$25
Prednisone	None	103	$901	$9

2018: 12 drugs

Sort by

Part D drugs prescribed in 2018

Radicava	None	50	$547,008	$10,940
Gamunex-C	Immune globulin	14	$199,752	$14,268
Nuedexta	None	36	$38,448	$1,068
Riluzole	None	45	$12,959	$288
Mycophenolate Mofetil	None	67	$11,718	$175
Pyridostigmine	None	40	$5,563	$139
Azathioprine	None	22	$1,958	$89
Gabapentin	None	80	$1,810	$23
Duloxetine	None	19	$1,538	$81
Methotrexate	None	34	$1,199	$35
Prednisone	None	114	$1,006	$9
Amitriptyline	None	12	$216	$18

2017: 10 drugs

Sort by

Part D drugs prescribed in 2017

Riluzole	52	$17,171	$330
Mycophenolate Mofetil	65	$12,909	$199
Pyridostigmine	24	$2,970	$124
Azathioprine	28	$2,508	$90
Gabapentin	76	$1,800	$24
Methotrexate	27	$1,712	$63
Prednisone	81	$799	$10
Amitriptyline	33	$602	$18
Glycopyrrolate	11	$358	$33
Baclofen	12	$288	$24

2016: 8 drugs

Sort by

Part D drugs prescribed in 2016

Mycophenolate Mofetil	54	$9,552	$177
Riluzole	53	$8,104	$153
Lyrica	19	$7,594	$400
Azathioprine	39	$1,873	$48
Gabapentin	88	$1,833	$21
Pyridostigmine	28	$1,709	$61
Baclofen	33	$943	$29
Prednisone	69	$824	$12

2015: 10 drugs

Sort by

Part D drugs prescribed in 2015

Gammagard Liquid	Immune globulin	20	$298,538	$14,927
Riluzole	None	51	$8,758	$172
Lyrica	None	13	$6,391	$492
Mycophenolate Mofetil	None	34	$5,817	$171
Gabapentin	None	59	$2,874	$49
Azathioprine	None	38	$2,551	$67
Pyridostigmine	None	16	$1,466	$92
Prednisone	None	64	$919	$14
Baclofen	None	32	$805	$25
Amitriptyline	None	13	$155	$12

2014: 5 drugs

Sort by

Part D drugs prescribed in 2014

Gammagard Liquid	Immune globulin	18	$268,082	$14,893
Gabapentin	None	43	$1,888	$44
Carbidopa-Levodopa	None	19	$919	$48
Azathioprine	None	11	$417	$38
Prednisone	None	17	$234	$14

2013: 3 drugs

Sort by

Part D drugs prescribed in 2013

Entacapone	17	$6,711	$395
Carbidopa-Levodopa	23	$1,325	$58
Gabapentin	31	$779	$25

Money from drug and device companies

$90,494 in 2025

Sort by

Industry payments by year

2025	8	83	$80,445	$90,494
2024	9	73	$79,952	$87,126
2023	6	49	$43,452	$46,850
2022	3	39	$25,510	$32,018
2021	2	4	$5,968	$5,968
2020	1	1	$1,020	$1,020
2019	2	17	$4,290	$6,884

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Janssen Biotech	None	$22,103	20 payments Travel · 2025-11-08 · $340 Travel · 2025-11-08 · $84 Consulting · 2025-11-04 · $4,995 Meals · 2025-10-28 · $52 Meals · 2025-10-28 · $59 Meals · 2025-09-11 · $54 Meals · 2025-09-11 · $26 Meals · 2025-07-12 · $12 Meals · 2025-07-12 · $25 Travel · 2025-07-12 · $197 Meals · 2025-07-12 · $37 Paid to speak or teach · 2025-07-07 · $14,100 Meals · 2025-06-13 · $8 Meals · 2025-06-11 · $42 Meals · 2025-06-10 · $83 Meals · 2025-06-10 · $17 Travel · 2025-06-10 · $739 Travel · 2025-06-10 · $604 Meals · 2025-06-10 · $14 Travel · 2025-06-10 · $616
Alexion Pharmaceuticals	None	$17,634	19 payments Paid to speak or teach · 2025-12-04 · $2,950 Consulting · 2025-11-12 · $5,310 Travel · 2025-11-12 · $33 Meals · 2025-10-29 · $120 Paid to speak or teach · 2025-08-07 · $4,720 Meals · 2025-07-31 · $28 Meals · 2025-07-31 · $22 Travel · 2025-07-31 · $456 Meals · 2025-07-31 · $15 Travel · 2025-07-31 · $67 Meals · 2025-07-31 · $133 Travel · 2025-07-31 · $12 Travel · 2025-07-31 · $67 Travel · 2025-07-31 · $371 Meals · 2025-04-07 · $48 Paid to speak or teach · 2025-02-20 · $2,950 Travel · 2025-02-12 · $95 Meals · 2025-02-12 · $119 Travel · 2025-02-12 · $118
Amgen	Uplizna	$14,314	13 payments Consulting for Uplizna · 2025-12-05 · $1,650 Paid to speak or teach · 2025-11-20 · $550 Consulting for Uplizna · 2025-10-01 · $1,650 Consulting for Uplizna · 2025-06-18 · $1,650 Consulting for Uplizna · 2025-05-15 · $550 Meals for Uplizna · 2025-05-13 · $16 Travel for Uplizna · 2025-02-13 · $147 Meals for Uplizna · 2025-02-13 · $98 Consulting for Uplizna · 2025-02-05 · $3,850 Consulting for Uplizna · 2025-02-05 · $2,750 Travel for Uplizna · 2025-01-31 · $1,105 Travel for Uplizna · 2025-01-31 · $148 Meals for Uplizna · 2025-01-31 · $149
Ucb	Zilbrysq	$12,231	9 payments Consulting · 2025-12-05 · $3,840 Travel · 2025-12-05 · $340 Meals · 2025-10-30 · $136 Paid to speak or teach · 2025-08-05 · $200 Consulting for Zilbrysq · 2025-07-31 · $640 Consulting for Zilbrysq · 2025-07-16 · $960 Travel · 2025-05-27 · $845 Consulting · 2025-05-27 · $5,120 Meals · 2025-04-07 · $150
Merck KGaA	None	$10,050	7 payments Consulting · 2025-12-04 · $2,360 Travel · 2025-12-02 · $340 Travel · 2025-12-02 · $1,180 Paid to speak or teach · 2025-12-02 · $3,540 Travel · 2025-01-02 · $240 Consulting · 2025-01-02 · $2,360 Travel · 2025-01-02 · $30
Janssen Scientific Affairs	None	$9,776	7 payments Consulting · 2025-11-27 · $1,110 Meals · 2025-10-28 · $149 Consulting · 2025-09-02 · $1,110 Consulting · 2025-09-01 · $1,090 Consulting · 2025-07-08 · $1,110 Consulting · 2025-04-03 · $1,665 Consulting · 2025-02-17 · $3,543

See all 83 published payments

Sort by

Every published payment

Argenx US	Consulting · 2025-12-08	None	$575
Ucb	Consulting · 2025-12-05	None	$3,840
Ucb	Travel · 2025-12-05	None	$340
Amgen	Consulting · 2025-12-05	Uplizna	$1,650
Alexion Pharmaceuticals	Paid to speak or teach · 2025-12-04	None	$2,950
Merck KGaA	Consulting · 2025-12-04	None	$2,360
Merck KGaA	Travel · 2025-12-02	None	$340
Merck KGaA	Travel · 2025-12-02	None	$1,180
Merck KGaA	Paid to speak or teach · 2025-12-02	None	$3,540
Janssen Scientific Affairs	Consulting · 2025-11-27	None	$1,110
Amgen	Paid to speak or teach · 2025-11-20	None	$550
Novartis Pharma AG	Consulting · 2025-11-18	Rhapsido	$3,038
Alexion Pharmaceuticals	Consulting · 2025-11-12	None	$5,310
Alexion Pharmaceuticals	Travel · 2025-11-12	None	$33
Janssen Biotech	Travel · 2025-11-08	None	$340
Janssen Biotech	Travel · 2025-11-08	None	$84
Janssen Biotech	Consulting · 2025-11-04	None	$4,995
Ucb	Meals · 2025-10-30	None	$136
Alexion Pharmaceuticals	Meals · 2025-10-29	None	$120
Janssen Scientific Affairs	Meals · 2025-10-28	None	$149
Janssen Biotech	Meals · 2025-10-28	None	$52
Janssen Biotech	Meals · 2025-10-28	None	$59
Amgen	Consulting · 2025-10-01	Uplizna	$1,650
Janssen Biotech	Meals · 2025-09-11	None	$54
Janssen Biotech	Meals · 2025-09-11	None	$26
Janssen Scientific Affairs	Consulting · 2025-09-02	None	$1,110
Janssen Scientific Affairs	Consulting · 2025-09-01	None	$1,090
Alexion Pharmaceuticals	Paid to speak or teach · 2025-08-07	None	$4,720
Ucb	Paid to speak or teach · 2025-08-05	None	$200
Alexion Pharmaceuticals	Meals · 2025-07-31	None	$28
Alexion Pharmaceuticals	Meals · 2025-07-31	None	$22
Alexion Pharmaceuticals	Travel · 2025-07-31	None	$456
Alexion Pharmaceuticals	Meals · 2025-07-31	None	$15
Alexion Pharmaceuticals	Travel · 2025-07-31	None	$67
Alexion Pharmaceuticals	Meals · 2025-07-31	None	$133
Alexion Pharmaceuticals	Travel · 2025-07-31	None	$12
Alexion Pharmaceuticals	Travel · 2025-07-31	None	$67
Alexion Pharmaceuticals	Travel · 2025-07-31	None	$371
Ucb	Consulting · 2025-07-31	Zilbrysq	$640
Ucb	Consulting · 2025-07-16	Zilbrysq	$960
Janssen Biotech	Meals · 2025-07-12	None	$12
Janssen Biotech	Meals · 2025-07-12	None	$25
Janssen Biotech	Travel · 2025-07-12	None	$197
Janssen Biotech	Meals · 2025-07-12	None	$37
Janssen Scientific Affairs	Consulting · 2025-07-08	None	$1,110
Janssen Biotech	Paid to speak or teach · 2025-07-07	None	$14,100
Amgen	Consulting · 2025-06-18	Uplizna	$1,650
Janssen Biotech	Meals · 2025-06-13	None	$8
Janssen Biotech	Meals · 2025-06-11	None	$42
Janssen Biotech	Meals · 2025-06-10	None	$83
Janssen Biotech	Meals · 2025-06-10	None	$17
Janssen Biotech	Travel · 2025-06-10	None	$739
Janssen Biotech	Travel · 2025-06-10	None	$604
Janssen Biotech	Meals · 2025-06-10	None	$14
Janssen Biotech	Travel · 2025-06-10	None	$616
Ucb	Travel · 2025-05-27	None	$845
Ucb	Consulting · 2025-05-27	None	$5,120
Amgen	Consulting · 2025-05-15	Uplizna	$550
Amgen	Meals · 2025-05-13	Uplizna	$16
Argenx US	Travel · 2025-05-09	Vyvgart Hytrulo	$62
Alexion Pharmaceuticals	Meals · 2025-04-07	None	$48
Ucb	Meals · 2025-04-07	None	$150
Argenx US	Meals · 2025-04-04	Vyvgart Hytrulo	$87
Argenx US	Meals · 2025-04-04	Vyvgart Hytrulo	$20
Argenx US	Meals · 2025-04-04	Vyvgart Hytrulo	$20
Argenx US	Meals · 2025-04-04	Vyvgart Hytrulo	$75
Janssen Scientific Affairs	Consulting · 2025-04-03	None	$1,665
Alexion Pharmaceuticals	Paid to speak or teach · 2025-02-20	None	$2,950
Janssen Scientific Affairs	Consulting · 2025-02-17	None	$3,543
Amgen	Travel · 2025-02-13	Uplizna	$147
Amgen	Meals · 2025-02-13	Uplizna	$98
Alexion Pharmaceuticals	Travel · 2025-02-12	None	$95
Alexion Pharmaceuticals	Meals · 2025-02-12	None	$119
Alexion Pharmaceuticals	Travel · 2025-02-12	None	$118
Amgen	Consulting · 2025-02-05	Uplizna	$3,850
Amgen	Consulting · 2025-02-05	Uplizna	$2,750
Amgen	Travel · 2025-01-31	Uplizna	$1,105
Amgen	Travel · 2025-01-31	Uplizna	$148
Amgen	Meals · 2025-01-31	Uplizna	$149
Argenx US	Consulting · 2025-01-07	Vyvgart Hytrulo	$510
Merck KGaA	Travel · 2025-01-02	None	$240
Merck KGaA	Consulting · 2025-01-02	None	$2,360
Merck KGaA	Travel · 2025-01-02	None	$30

See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $87,126

Sort by

Payments by company in 2024

Ucb	Zilbrysq	$38,309	26 payments Consulting for Rystiggo · 2024-09-05 · $4,152 Consulting · 2024-08-21 · $7,680 Consulting · 2024-07-25 · $6,400 Meals · 2024-07-03 · $25 Meals · 2024-07-03 · $25 Meals · 2024-07-03 · $50 Meals · 2024-07-03 · $50 Meals · 2024-07-03 · $135 Meals for Zilbrysq · 2024-03-26 · $19 Meals for Zilbrysq · 2024-03-26 · $19 Meals for Zilbrysq · 2024-03-26 · $32 Meals for Zilbrysq · 2024-03-26 · $44 Travel for Zilbrysq · 2024-03-26 · $45 Travel for Zilbrysq · 2024-03-26 · $56 Travel for Zilbrysq · 2024-03-26 · $60 Consulting for Zilbrysq · 2024-03-26 · $5,120 Consulting for Zilbrysq · 2024-03-26 · $5,120 Travel · 2024-03-08 · $23 Meals · 2024-03-08 · $46 Travel · 2024-03-08 · $59 Meals · 2024-02-26 · $25 Meals · 2024-02-26 · $125 Travel · 2024-02-26 · $772 Meals · 2024-02-08 · $87 Travel · 2024-02-08 · $1,101 Consulting · 2024-02-08 · $7,040
Alexion Pharmaceuticals	Soliris	$16,394	19 payments Travel · 2024-10-25 · $241 Meals · 2024-10-25 · $132 Travel · 2024-10-25 · $48 Paid to speak or teach · 2024-10-25 · $4,720 Travel · 2024-10-25 · $48 Meals for Ultomiris · 2024-10-24 · $112 Meals for Ultomiris · 2024-10-14 · $20 Travel · 2024-08-21 · $89 Travel · 2024-08-21 · $111 Meals · 2024-08-21 · $126 Paid to speak or teach · 2024-08-21 · $3,540 Consulting for Soliris · 2024-05-07 · $5,900 Meals for Ultomiris · 2024-04-13 · $54 Meals for Soliris · 2024-04-13 · $113 Meals for Soliris · 2024-04-12 · $21 Meals for Soliris · 2024-04-12 · $34 Travel for Soliris · 2024-04-12 · $331 Meals for Soliris · 2024-04-12 · $18 Paid to speak or teach for Ultomiris · 2024-02-29 · $738
Amgen	Uplizna	$12,597	14 payments Travel for Uplizna · 2024-11-06 · $363 Travel for Uplizna · 2024-11-06 · $38 Consulting for Uplizna · 2024-11-01 · $3,850 Meals for Uplizna · 2024-10-18 · $119 Meals for Uplizna · 2024-08-19 · $162 Travel for Uplizna · 2024-08-19 · $98 Consulting for Uplizna · 2024-07-23 · $3,850 Consulting for Uplizna · 2024-07-23 · $2,750 Travel for Uplizna · 2024-07-13 · $177 Travel for Uplizna · 2024-07-13 · $351 Meals for Uplizna · 2024-07-13 · $45 Meals for Uplizna · 2024-07-13 · $45 Meals for Uplizna · 2024-07-13 · $60 Travel for Uplizna · 2024-06-27 · $689
Argenx US	Vyvgart	$8,471	5 payments Paid to speak or teach for Vyvgart · 2024-11-29 · $2,550 Consulting for Vyvgart · 2024-09-05 · $510 Consulting for Vyvgart · 2024-07-09 · $1,020 Travel for Vyvgart · 2024-05-22 · $311 Consulting for Vyvgart · 2024-05-22 · $4,080
Ucb Sa	Rystiggo	$3,575	2 payments Consulting · 2024-06-14 · $2,750 Consulting for Rystiggo · 2024-05-03 · $825
Johnson & Johnson Health Care Systems	None	$2,725	1 payment Consulting · 2024-04-29 · $2,725
Janssen Global Services	None	$2,603	4 payments Consulting · 2024-11-18 · $2,180 Travel · 2024-05-20 · $311 Meals · 2024-04-18 · $92 Meals · 2024-04-18 · $20
Janssen Biotech	None	$1,635	1 payment Consulting · 2024-05-13 · $1,635
Janssen Scientific Affairs	None	$818	1 payment Consulting · 2024-05-20 · $818

2023: $46,850

Sort by

Payments by company in 2023

Alexion Pharmaceuticals	Soliris	$17,724	9 payments Consulting for Ultomiris · 2023-11-30 · $2,065 Paid to speak or teach · 2023-11-09 · $4,720 Meals · 2023-11-01 · $119 Paid to speak or teach · 2023-06-13 · $2,950 Consulting · 2023-06-07 · $4,720 Consulting for Soliris · 2023-06-01 · $2,950 Meals · 2023-05-19 · $60 Meals for Ultomiris · 2023-05-05 · $34 Meals for Ultomiris · 2023-04-27 · $106
Argenx US	Vyvgart	$9,638	16 payments Meals for Vyvgart · 2023-11-21 · $35 Travel for Vyvgart · 2023-11-21 · $43 Travel for Vyvgart · 2023-11-21 · $73 Travel for Vyvgart · 2023-11-21 · $390 Consulting for Vyvgart · 2023-11-21 · $2,138 Meals for Vyvgart · 2023-10-31 · $16 Meals for Vyvgart · 2023-10-31 · $24 Meals for Vyvgart · 2023-10-31 · $62 Meals for Vyvgart · 2023-10-31 · $117 Meals for Vyvgart · 2023-10-31 · $54 Meals for Vyvgart · 2023-10-31 · $4 Consulting for Vyvgart · 2023-05-31 · $4,080 Travel for Vyvgart · 2023-05-31 · $660 Travel for Vyvgart · 2023-05-31 · $434 Meals for Vyvgart · 2023-04-24 · $86 Consulting for Vyvgart · 2023-04-20 · $1,425
Ucb	None	$9,603	13 payments Meals · 2023-11-18 · $28 Meals · 2023-11-18 · $29 Meals · 2023-11-18 · $65 Meals · 2023-11-18 · $81 Travel · 2023-11-18 · $181 Meals · 2023-11-04 · $90 Meals · 2023-11-03 · $128 Consulting · 2023-04-26 · $4,400 Consulting · 2023-04-26 · $4,400 Consulting · 2023-04-25 · $32 Consulting · 2023-04-25 · $32 Meals · 2023-04-25 · $69 Meals · 2023-04-25 · $69
Janssen Global Services	None	$4,641	5 payments Travel · 2023-12-20 · $173 Consulting · 2023-12-20 · $3,543 Meals · 2023-11-04 · $18 Meals · 2023-11-04 · $91 Consulting · 2023-05-10 · $818
Amgen	None	$3,000	2 payments Consulting · 2023-10-27 · $2,400 Consulting · 2023-10-27 · $600
Janssen Scientific Affairs	None	$2,244	4 payments Meals · 2023-04-26 · $12 Meals · 2023-04-26 · $12 Consulting · 2023-04-26 · $2,180 Meals · 2023-04-26 · $40

2022: $32,018

Sort by

Payments by company in 2022

Argenx US	Vyvgart	$12,163	20 payments Consulting for Vyvgart · 2022-11-09 · $5,100 Travel for Vyvgart · 2022-11-09 · $108 Travel for Vyvgart · 2022-11-09 · $218 Meals for Vyvgart · 2022-11-09 · $113 Meals for Vyvgart · 2022-11-09 · $40 Travel for Vyvgart · 2022-11-09 · $91 Consulting for Vyvgart · 2022-11-02 · $2,613 Travel for Vyvgart · 2022-11-02 · $606 Travel for Vyvgart · 2022-11-02 · $289 Travel for Vyvgart · 2022-11-02 · $97 Meals for Vyvgart · 2022-11-02 · $99 Travel for Vyvgart · 2022-10-29 · $248 Travel for Vyvgart · 2022-10-29 · $319 Travel for Vyvgart · 2022-10-28 · $697 Travel for Vyvgart · 2022-10-28 · $322 Meals for Vyvgart · 2022-09-20 · $71 Meals for Vyvgart · 2022-09-20 · $46 Meals for Vyvgart · 2022-09-20 · $73 Meals for Vyvgart · 2022-07-14 · $63 Consulting · 2022-06-29 · $950
Alexion Pharmaceuticals	Ultomiris	$11,777	9 payments Paid to speak or teach · 2022-12-06 · $2,550 Meals · 2022-11-30 · $79 Paid to speak or teach for Ultomiris · 2022-10-04 · $3,188 Meals for Ultomiris · 2022-09-21 · $97 Paid to speak or teach · 2022-08-25 · $2,550 Meals · 2022-08-17 · $125 Consulting for Soliris · 2022-06-10 · $1,530 Meals for Ultomiris · 2022-05-11 · $128 Paid to speak or teach · 2022-03-15 · $1,530
Ucb	None	$8,078	10 payments Meals · 2022-09-22 · $129 Meals · 2022-07-16 · $136 Meals · 2022-06-18 · $18 Meals · 2022-06-18 · $41 Meals · 2022-06-18 · $66 Travel · 2022-06-18 · $405 Travel · 2022-06-18 · $444 Travel · 2022-06-18 · $1,261 Consulting · 2022-06-18 · $5,500 Travel · 2022-06-17 · $79

2021: $5,968

Sort by

Payments by company in 2021

Ucb	None	$3,163	1 payment Consulting · 2021-12-13 · $3,163
Alexion Pharmaceuticals	None	$2,805	3 payments Paid to speak or teach · 2021-09-02 · $1,020 Paid to speak or teach · 2021-07-27 · $1,020 Paid to speak or teach · 2021-06-17 · $765

2020: $1,020

Sort by

Payments by company in 2020

Alexion Pharmaceuticals	Soliris	$1,020	1 payment Consulting for Soliris · 2020-11-03 · $1,020

2019: $6,884

Sort by

Payments by company in 2019

CSL Behring	Hizentra	$5,177	8 payments Education for Hizentra · 2019-04-01 · $55 Education for Hizentra · 2019-04-01 · $55 Meals for Hizentra · 2019-03-23 · $142 Travel for Hizentra · 2019-03-23 · $162 Travel for Hizentra · 2019-03-23 · $173 Travel for Hizentra · 2019-03-23 · $211 Honoraria for Hizentra · 2019-03-23 · $4,290 Meals for Hizentra · 2019-03-22 · $90
Ucb Sa	None	$1,707	9 payments Travel · 2019-10-10 · $248 Meals · 2019-09-07 · $124 Travel · 2019-09-07 · $213 Meals · 2019-09-07 · $26 Meals · 2019-09-07 · $30 Meals · 2019-09-07 · $50 Meals · 2019-09-07 · $50 Travel · 2019-09-06 · $171 Travel · 2019-09-06 · $796

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

Alexion Pharmaceuticals, Inc. · A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study With An Open-Label Extension To Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis (Als) · 2021	Their institution	$86,828
Takeda Pharmaceuticals U.S.A., Inc. · A Phase 2, Randomized, Placebo-Controlled Study To Evaluate Safety, Tolerability, and Efficacy of Tak-079 in Patients With Generalized Myasthenia Gravis · 2021	Their institution	$81,957
ARGENX US, INC. · Assessing Glucocorticoid Associated Toxicity in Myasthenia Gravis Using Glucocorticoid Toxicity Index (Gti)/Argenx · 2024	Their institution	$66,132
Alexion Pharmaceuticals, Inc. · A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study To Evaluate the Efficacy and Safety of Ravulizumab in Patients With Amyotrophic Lateral Sclerosis Participants With C3g Based on Histologic Scoring and Proteinuria · 2022	Their institution	$24,618
Takeda Pharmaceuticals U.S.A., Inc. · A Phase 2, Randomized, Placebo-Controlled Study To Evaluate Safety, Tolerability, and Efficacy of Tak-079 in Patients With Generalized Myasthenia Gravis · 2022	Their institution	$16,792
UCB SA · A Multicenter, Open-Label Study To Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate To Severe Chronic Plaque Psoriasis · 2023	This clinician	$14,304
UCB SA · A Phase 3, Randomized, Doubl-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis · 2020	Their institution	$13,755
UCB SA · A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis · 2019	Their institution	$6,423
UCB SA · A Multicenter, Randomized, Double-Blind, Secukinumab-Controlled, Parallel-Group Study To Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate To Severe Chronic Plaque Psoriasis. · 2023	This clinician	$2,531
Takeda Pharmaceuticals U.S.A., Inc. · A Phase 2, Randomized, Placebo-Controlled Study To Evaluate Safety, Tolerability, and Efficacy of Tak-079 in Patients With Generalized Myasthenia Gravis · 2023	Their institution	$430

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1558500256
Licence: CA A106343California A106343: Current · expires 2028-11-30
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Neurology (2084N0400X); Federal specialty code 204R00000X (204R00000X); Federal specialty code 2084N0600X (2084N0600X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2009-02-19
NPI last updated: 2023-11-10
NPI record certified: 2023-11-10

This is when the NPI record was last certified, not a medical board exam.